Zirui Dong
Union Hospital
Wuhan, 430022, China
Wuhan, 430022, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
CA9-Targeted PET Imaging for Noninvasive Discrimination of Clear Cell Renal Cell Carcinoma and Associated Tumor Biological Features.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: February 23, 2026
PRKAB2 as a tumor suppressor in renal cell carcinoma: inhibiting mitophagy via the LRPPRC-PRKN/parkin interaction and cardiolipin biosynthesis.
Journal: Autophagy
Published: January 30, 2026
Recent progress on tyrosine kinase inhibitors resistance in renal cell carcinoma: another brick in the wall?
Journal: Cancer drug resistance (Alhambra, Calif.)
Published: August 01, 2025
Cardiovascular Safety Landscape of ADT in Prostate Cancer Treatment Based on Real-World Analysis.
Journal: Cancer medicine
Published: June 24, 2025
Anticancer Drugs Associated With Tumor Lysis Syndrome: Insights From the US Food and Drug Administration Adverse Event Reporting System.
Journal: Clinical therapeutics
Published: April 27, 2025
Epigenetically silenced KAT2B suppresses de novo lipogenesis through destroying HDAC5/LSD1 complex assembly in renal cell carcinoma.
Journal: Journal of advanced research
Published: January 14, 2025
PUMA reduces FASN ubiquitination to promote lipid accumulation and tumor progression in human clear cell renal cell carcinoma.
Journal: Cell death & disease
Published: October 06, 2024
Photothermal therapy: a novel potential treatment for prostate cancer.
Journal: Biomaterials science
Published: April 09, 2024
Showing 1-8 of 8
Last Updated: 09/26/2026